TY - JOUR
T1 - Prevalence and cardiac phenotype of patients with a phospholamban mutation
AU - Hof, I. E.
AU - van der Heijden, J. F.
AU - Kranias, E. G.
AU - Sanoudou, D.
AU - de Boer, R. A.
AU - van Tintelen, J. P.
AU - van der Zwaag, P. A.
AU - Doevendans, P. A.
N1 - Publisher Copyright:
© 2018, The Author(s).
PY - 2019/2
Y1 - 2019/2
N2 - Pathogenic mutations in the phospholamban (PLN) gene may give rise to inherited cardiomyopathies due to its role in calcium homeostasis. Several PLN mutations have been identified, with the R14del mutation being the most prevalent cardiomyopathy-related mutation in the Netherlands. It is present in patients diagnosed with arrhythmogenic cardiomyopathy as well as dilated cardiomyopathy. Awareness of the phenotype of this PLN mutation is of great importance, since many carriers remain to be identified. Patients with the R14del mutation are characterised by older age at onset, low-voltage electrocardiograms and a high frequency of ventricular arrhythmias. Additionally, these patients have a poor prognosis often with left ventricular dysfunction and early-onset heart failure. Therefore, when there is a suspicion of a PLN mutation, cardiac and genetic screening is strongly recommended.
AB - Pathogenic mutations in the phospholamban (PLN) gene may give rise to inherited cardiomyopathies due to its role in calcium homeostasis. Several PLN mutations have been identified, with the R14del mutation being the most prevalent cardiomyopathy-related mutation in the Netherlands. It is present in patients diagnosed with arrhythmogenic cardiomyopathy as well as dilated cardiomyopathy. Awareness of the phenotype of this PLN mutation is of great importance, since many carriers remain to be identified. Patients with the R14del mutation are characterised by older age at onset, low-voltage electrocardiograms and a high frequency of ventricular arrhythmias. Additionally, these patients have a poor prognosis often with left ventricular dysfunction and early-onset heart failure. Therefore, when there is a suspicion of a PLN mutation, cardiac and genetic screening is strongly recommended.
UR - https://www.scopus.com/pages/publications/85060865503
U2 - 10.1007/s12471-018-1211-4
DO - 10.1007/s12471-018-1211-4
M3 - Article
C2 - 30547415
AN - SCOPUS:85060865503
SN - 1568-5888
VL - 27
SP - 64
EP - 69
JO - Netherlands Heart Journal
JF - Netherlands Heart Journal
IS - 2
ER -